KIMS Announces 24th AGM on Aug 27, 2026, to Discuss FY26 Financials & Director Re-appointment
Krishna Institute of Medical Sciences Limited (KIMS) will hold its 24th AGM on August 27, 2026, via VC/OAVM. The meeting will adopt audited standalone and consolidated financial statements for FY26 and re-appoint Director Ms. Dandamudi Anitha. Members will also vote on approving loans/guarantees up to ₹650 crore and ratifying cost auditor remuneration.
The AGM agenda includes the approval of financial statements and significant financial authorities (loans/guarantees up to ₹650 crore), which are material for shareholders and the company's operational flexibility.
The announcement is a routine corporate event (AGM notice) detailing the agenda, which includes financial statement adoption and director re-appointment, along with approvals for financial transactions. It does not contain new financial performance data or significant strategic shifts that would strongly influence sentiment.
Krishna Institute of Medical Sciences Limited (KIMS) has announced the convening of its 24th Annual General Meeting (AGM) on Thursday, August 27, 2026, at 4:00 PM IST. The meeting will be conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM) and will form part of the Integrated Annual Report for the Financial Year 2025-26.
The agenda for the AGM includes the consideration and adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, along with the respective Board and Auditor reports. Additionally, the members will vote on the re-appointment of Ms. Dandamudi Anitha as a Director, who retires by rotation.
Special business to be transacted includes the ratification of remuneration for the Cost Auditors, M/s. Sagar & Associates, for the financial year 2026-27, amounting to ₹6.00 Lakhs excluding applicable taxes. Furthermore, the members will be asked to approve the granting of loans, guarantees, or securities under Section 185 of the Companies Act, 2013, up to a sum not exceeding ₹650 crore. The members will also consider and approve overall limits under Section 186 of the Companies Act, 2013, for loans, guarantees, securities, and investments by the company, also up to an aggregate amount not exceeding ₹650 crore.
Remote e-voting will commence on August 24, 2026, at 9:00 AM IST and conclude on August 26, 2026, at 5:00 PM IST. The record date for determining the eligibility of members for e-voting is August 20, 2026.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.